NEOFLO
Globus Medical, Inc.
Mark For: NEOFLO™ trademark registration is intended to cover the category of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 97330350 |
| Mark Literal Elements | NEOFLO |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | Trademark |
| Current Location | INTENT TO USE SECTION 2023-03-21 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Mehul Jani |
| Attorney Docket Number | 0218.592TM02 |
Timeline
| 2022-03-25 | Application Filed |
| 2022-03-29 | Location: NEW APPLICATION PROCESSING |
| 2022-03-29 | Status: Live/Pending |
| 2022-03-29 | Transaction Date |
| 2023-01-24 | Published |
| 2023-03-21 | Location: INTENT TO USE SECTION |
| 2023-09-21 | Status: A first request for extension of time to file a Statement of Use has been granted. |
Trademark Parties (Applicants & Owners)
| Party: |  Globus Medical, Inc. |
| Address | 2560 General Armistead Avenue Audubon, PENNSYLVANIA UNITED STATES 19403 |
| Legal Entity Type | Corporation |
| Legal Entity State | PENNSYLVANIA |
Documents
 Application | 2022-03-25 | |
| Drawing | 2022-03-25 | |
| XSearch Search Summary | 2022-12-15 | |
| Examiner's Amendment | 2022-12-16 | |
| Public Note | 2022-12-16 | |
| Amendment and Mail Process Complete | 2022-12-17 | |
| TRAM Snapshot of App at Pub for Oppostn | 2022-12-17 | |
| Notice of Publication | 2023-01-04 | |
| Notification Of Notice of Publication | 2023-01-04 | |
| OG Publication Confirmation | 2023-01-24 | |
| Notice of Allowance | 2023-03-21 | |
| Extension of Time to File SOU | 2023-09-21 | |
| ITU Extension Approval | APPLICATION/XML | 2023-09-23 |
| ITU Unit Action | 2023-09-23 |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Allograft containing amniotic fluid |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-09-23 | |
| SOU TEAS EXTENSION RECEIVED | 2023-09-21 | |
| SOU EXTENSION 1 GRANTED | 2023-09-21 | |
| SOU EXTENSION 1 FILED | 2023-09-21 | |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2023-03-21 | |
| PUBLISHED FOR OPPOSITION | 2023-01-24 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2023-01-24 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2023-01-04 | |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2022-12-16 | |
| EXAMINERS AMENDMENT E-MAILED | 2022-12-16 | |
| EXAMINERS AMENDMENT -WRITTEN | 2022-12-16 | |
| EXAMINER'S AMENDMENT ENTERED | 2022-12-16 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2022-12-16 | |
| ASSIGNED TO EXAMINER | 2022-12-14 | |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2022-03-30 | |
| NEW APPLICATION ENTERED IN TRAM | 2022-03-29 | |
| NEW APPLICATION ENTERED | 2022-03-29 |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 